- Home
- ITRM vs PRT Comparison
ITRM vs PRT Comparison
Compare ITRM & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- PRT
- Stock Information
- Founded
- ITRM 2015
- PRT 2017
- Country
- ITRM Ireland
- PRT United States
- Employees
- ITRM N/A
- PRT N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- PRT Oil & Gas Production
- Sector
- ITRM Health Care
- PRT Energy
- Exchange
- ITRM Nasdaq
- PRT Nasdaq
- Market Cap
- ITRM 49.5M
- PRT 45.4M
- IPO Year
- ITRM 2018
- PRT N/A
- Fundamental
- Price
- ITRM $1.75
- PRT $3.37
- Analyst Decision
- ITRM Strong Buy
- PRT
- Analyst Count
- ITRM 1
- PRT 0
- Target Price
- ITRM $5.00
- PRT N/A
- AVG Volume (30 Days)
- ITRM 1.6M
- PRT 49.6K
- Earning Date
- ITRM 11-14-2024
- PRT 11-13-2024
- Dividend Yield
- ITRM N/A
- PRT 12.13%
- EPS Growth
- ITRM N/A
- PRT N/A
- EPS
- ITRM N/A
- PRT 0.42
- Revenue
- ITRM N/A
- PRT $6,059,380.00
- Revenue This Year
- ITRM N/A
- PRT N/A
- Revenue Next Year
- ITRM N/A
- PRT N/A
- P/E Ratio
- ITRM N/A
- PRT $8.17
- Revenue Growth
- ITRM N/A
- PRT N/A
- 52 Week Low
- ITRM $0.81
- PRT $3.27
- 52 Week High
- ITRM $3.02
- PRT $5.03
- Technical
- Relative Strength Index (RSI)
- ITRM 45.98
- PRT 36.42
- Support Level
- ITRM $1.78
- PRT $3.41
- Resistance Level
- ITRM $1.95
- PRT $4.05
- Average True Range (ATR)
- ITRM 0.30
- PRT 0.14
- MACD
- ITRM -0.10
- PRT -0.03
- Stochastic Oscillator
- ITRM 0.00
- PRT 26.82
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.